Literature DB >> 23716044

A new ABC half-transporter in Leishmania major is involved in resistance to antimony.

J I Manzano1, R García-Hernández, S Castanys, F Gamarro.   

Abstract

The characterization of ABCI4, a new intracellular ATP-binding cassette (ABC) half-transporter in Leishmania major, is described. We show that ABCI4 is involved in heavy metal export, thereby conferring resistance to Pentostam, to Sb(III), and to As(III) and Cd(II). Parasites overexpressing ABCI4 showed a lower mitochondrial toxic effect of antimony by decreasing reactive oxygen species production and maintained higher values of both the mitochondrial electrochemical potential and total ATP levels with respect to controls. The ABCI4 half-transporter forms homodimers as determined by a coimmunoprecipitation assay. A combination of subcellular localization studies under a confocal microscope and a surface biotinylation assay using parasites expressing green fluorescent protein- and FLAG-tagged ABCI4 suggests that the transporter presents a dual localization in both mitochondria and the plasma membrane. Parasites overexpressing ABCI4 present an increased replication in mouse peritoneal macrophages. We have determined that porphyrins are substrates for ABCI4. Consequently, the overexpression of ABCI4 confers resistance to some toxic porphyrins, such as zinc-protoporphyrin, due to the lower accumulation resulting from a significant efflux, as determined using the fluorescent zinc-mesoporphyrin, a validated heme analog. In addition, ABCI4 has a significant ability to efflux thiol after Sb(III) incubation, thus meaning that ABCI4 could be considered to be a potential thiol-X-pump that is able to recognize metal-conjugated thiols. In summary, we have shown that this new ABC transporter is involved in drug sensitivity to antimony and other compounds by efflux as conjugated thiol complexes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716044      PMCID: PMC3719772          DOI: 10.1128/AAC.00211-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

Review 1.  Drug combinations for visceral leishmaniasis.

Authors:  Piero L Olliaro
Journal:  Curr Opin Infect Dis       Date:  2010-12       Impact factor: 4.915

2.  Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials.

Authors:  Philippe Leprohon; Danielle Légaré; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

3.  Use of the green fluorescent protein as a marker in transfected Leishmania.

Authors:  D S Ha; J K Schwarz; S J Turco; S M Beverley
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

4.  Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.

Authors:  José Ignacio Manzano; Luis Carvalho; José M Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

5.  Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania.

Authors:  A Haimeur; C Guimond; S Pilote; R Mukhopadhyay; B P Rosen; R Poulin; M Ouellette
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

6.  Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.

Authors:  Csilla Ozvegy; András Váradi; Balázs Sarkadi
Journal:  J Biol Chem       Date:  2002-10-08       Impact factor: 5.157

7.  Mechanism of metalloid-induced death in Leishmania spp.: role of iron, reactive oxygen species, Ca2+, and glutathione.

Authors:  Ashish Mehta; Chandrima Shaha
Journal:  Free Radic Biol Med       Date:  2006-02-17       Impact factor: 7.376

8.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

Authors:  R Mukhopadhyay; S Dey; N Xu; D Gage; J Lightbody; M Ouellette; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump.

Authors:  Z S Li; M Szczypka; Y P Lu; D J Thiele; P A Rea
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

10.  Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony.

Authors:  G Mandal; S Wyllie; N Singh; S Sundar; A H Fairlamb; M Chatterjee
Journal:  Parasitology       Date:  2007-07-05       Impact factor: 3.234

View more
  24 in total

1.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 2.  Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Gul Majid Khan
Journal:  J Nanobiotechnology       Date:  2021-04-15       Impact factor: 10.435

Review 3.  Dependence of Leishmania parasite on host derived ATP: an overview of extracellular nucleotide metabolism in parasite.

Authors:  Kashika Arora; Ambak Kumar Rai
Journal:  J Parasit Dis       Date:  2018-12-01

Review 4.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

5.  4-amino bis-pyridinium derivatives as novel antileishmanial agents.

Authors:  Verónica Gómez-Pérez; José Ignacio Manzano; Raquel García-Hernández; Santiago Castanys; Joaquín M Campos Rosa; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 6.  Microbial Antimony Biogeochemistry: Enzymes, Regulation, and Related Metabolic Pathways.

Authors:  Jingxin Li; Qian Wang; Ronald S Oremland; Thomas R Kulp; Christopher Rensing; Gejiao Wang
Journal:  Appl Environ Microbiol       Date:  2016-08-30       Impact factor: 4.792

7.  The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.

Authors:  Luis Carvalho; Marta Martínez-García; Ignacio Pérez-Victoria; José Ignacio Manzano; Vanessa Yardley; Francisco Gamarro; José M Pérez-Victoria
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

8.  In vitro efficacy of ethanolic extract of Artemisia absinthium (Asteraceae) against Leishmania major L. using cell sensitivity and flow cytometry assays.

Authors:  Kourosh Azizi; Fatemeh Shahidi-Hakak; Qasem Asgari; Gholam Reza Hatam; Mohammad Reza Fakoorziba; Ramin Miri; Mohammad Djaefar Moemenbellah-Fard
Journal:  J Parasit Dis       Date:  2014-09-20

9.  The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.

Authors:  Ana Perea; José Ignacio Manzano; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.

Authors:  Talia Arcari; José Ignacio Manzano; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.